Evidence map›Paper›PMID 41114579›Full record

ArticlemSphere2025

Cultured bacteria isolated from primary sclerosing cholangitis patient bile induce inflammation and cell death.

Chelsea E Powell, Megan D McCurry, Silvia Fernanda Quevedo, Lindsay Ventura, Kumar Krishnan, Malav Dave, Shaikh Danish Mahmood, Katherine Specht, Raghav Bordia, Molly R Sargen and 3 more

Abstract read
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Chelsea E PowellDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-7624-1116
Megan D McCurryDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Silvia Fernanda QuevedoDivision of Gastroenterology, Hepatology and Endoscopy, Brigham & Women's Hospital, Boston, Massachusetts, USA.
Lindsay VenturaAutoimmune and Cholestatic Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kumar KrishnanAutoimmune and Cholestatic Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Malav DaveDivision of Gastroenterology, Hepatology and Endoscopy, Brigham & Women's Hospital, Boston, Massachusetts, USA.
Shaikh Danish MahmoodDivision of Gastroenterology, Hepatology and Endoscopy, Brigham & Women's Hospital, Boston, Massachusetts, USA.
Katherine SpechtAutoimmune and Cholestatic Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Raghav BordiaAutoimmune and Cholestatic Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Molly R SargenDepartment of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.
Daniel S PrattAutoimmune and Cholestatic Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Joshua R KorzenikDivision of Gastroenterology, Hepatology and Endoscopy, Brigham & Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-7692-5710
A Sloan DevlinDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-5598-3751

Funding

Human microbiome metabolites in health and diseaseR35GM128618 · NIGMS · HARVARD MEDICAL SCHOOL · PI Abigail Sloan Devlin · 2018 to 2026
$4.1M
NIGMS NIH HHS GM128618NIGMS NIH HHS R35 GM128618
6 · The paper itself

Abstract

Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by inflammation and progressive fibrosis of the biliary tree. PSC pathogenesis remains poorly understood, and there are no effective therapies. Previous studies have observed associations between colonic and biliary microbiome alterations and PSC. We aimed to determine whether bacterial isolates cultured from PSC patient bile induce disease-associated phenotypes in cells, specifically cell death, epithelial permeability, inflammation, and changes in host-protective pathways. Bile was collected from PSC patients by endoscopic retrograde cholangiography and from non-PSC controls undergoing cholecystectomies. Biliary bacteria were cultured anaerobically, and 50 colonies per sample were identified by 16S sequencing. No bacteria were isolated from non-PSC controls, while bacteria were cultured from most PSC patients. The PSC bile microbiomes exhibited reduced diversity compared to the gut or oral cavity, with one or two species predominating. The effects of supernatants from seven PSC-associated bacterial isolates on cellular phenotypes were characterized using human colonic (Caco-2), hepatic (HepG2), and biliary (EGI-1) cells. Overall, PSC-associated bacteria produced factors cytotoxic to hepatic and biliary cells. An

Indexed as

BacteriaBileCell DeathCholangitis, SclerosingInflammationAdultCaco-2 CellsEpithelial CellsFemaleHumansMaleMicrobiotaMiddle AgedRNA, Ribosomal, 16SRNA, Ribosomal, 16Sbacterial isolatesbiliary microbiomecellular assayscellular phenotypeprimary sclerosing cholangitis

Identifiers

PMID41114579
PMCPMC12645923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.